PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Shanghai Pharmaceuticals Holding Co Ltd (2607.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINCNE1000012B3
SectorHealthcare
IndustryMedical Distribution

Highlights

Market CapHK$62.49B
EPSHK$1.45
PE Ratio9.09
PEG Ratio2.35
Revenue (TTM)HK$254.88B
Gross Profit (TTM)HK$28.41B
EBITDA (TTM)HK$10.18B
Year RangeHK$10.32 - HK$15.83
Target PriceHK$16.56

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with 2607.HK

Shanghai Pharmaceuticals Holding Co Ltd

Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in Shanghai Pharmaceuticals Holding Co Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%500.00%1,000.00%1,500.00%OctoberNovemberDecember2024FebruaryMarch
1,418.82%
256.47%
2607.HK (Shanghai Pharmaceuticals Holding Co Ltd)
Benchmark (^GSPC)

S&P 500

Returns By Period

Shanghai Pharmaceuticals Holding Co Ltd had a return of 1.05% year-to-date (YTD) and -19.31% in the last 12 months. Over the past 10 years, Shanghai Pharmaceuticals Holding Co Ltd had an annualized return of -0.96%, while the S&P 500 had an annualized return of 10.96%, indicating that Shanghai Pharmaceuticals Holding Co Ltd did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date1.05%10.04%
1 month-6.94%3.53%
6 months-5.87%22.79%
1 year-19.31%32.16%
5 years (annualized)-4.08%13.15%
10 years (annualized)-0.96%10.96%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-3.33%14.13%
2023-8.64%-5.27%-6.87%-0.53%0.88%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Shanghai Pharmaceuticals Holding Co Ltd (2607.HK) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
2607.HK
Shanghai Pharmaceuticals Holding Co Ltd
-0.73
^GSPC
S&P 500
2.76

Sharpe Ratio

The current Shanghai Pharmaceuticals Holding Co Ltd Sharpe ratio is -0.73. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
-0.73
2.74
2607.HK (Shanghai Pharmaceuticals Holding Co Ltd)
Benchmark (^GSPC)

Dividends

Dividend History

Shanghai Pharmaceuticals Holding Co Ltd granted a 5.75% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.66 per share.


PeriodTTM20232022202120202019201820172016201520142013
DividendHK$0.66HK$0.66HK$0.49HK$0.58HK$0.48HK$0.47HK$0.46HK$0.41HK$0.39HK$0.37HK$0.33HK$0.30

Dividend yield

5.75%5.81%3.79%3.90%3.53%3.08%2.90%1.95%2.19%2.19%1.87%1.59%

Monthly Dividends

The table displays the monthly dividend distributions for Shanghai Pharmaceuticals Holding Co Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024HK$0.00HK$0.00
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.66HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.49HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.58HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.48HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2019HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.47HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2018HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.46HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2017HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.41HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2016HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.39HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2015HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.37HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2014HK$0.00HK$0.00HK$0.00HK$0.00HK$0.33HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2013HK$0.30HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%5.8%
Shanghai Pharmaceuticals Holding Co Ltd has a dividend yield of 5.75%, which means its dividend payment is significantly above the market average.
Payout Ratio
200.0%400.0%600.0%800.0%45.8%
Shanghai Pharmaceuticals Holding Co Ltd has a payout ratio of 45.78%, which is quite average when compared to the overall market. This suggests that Shanghai Pharmaceuticals Holding Co Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-48.17%
0
2607.HK (Shanghai Pharmaceuticals Holding Co Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Shanghai Pharmaceuticals Holding Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Shanghai Pharmaceuticals Holding Co Ltd was 99.49%, occurring on Sep 23, 2008. Recovery took 658 trading sessions.

The current Shanghai Pharmaceuticals Holding Co Ltd drawdown is 48.17%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.49%Nov 9, 2007215Sep 23, 2008658May 20, 2011873
-61.7%May 27, 2011250May 29, 2012703Apr 2, 2015953
-56.01%May 20, 20151195Mar 19, 2020
-15.34%Sep 25, 20071Sep 25, 200719Oct 25, 200720
-9.59%Apr 14, 201517May 7, 20155May 14, 201522

Volatility

Volatility Chart

The current Shanghai Pharmaceuticals Holding Co Ltd volatility is 7.84%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%OctoberNovemberDecember2024FebruaryMarch
7.84%
2.82%
2607.HK (Shanghai Pharmaceuticals Holding Co Ltd)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Shanghai Pharmaceuticals Holding Co Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items